Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial. (2016)
Attributed to:
Centre for Cognitive Ageing & Cognitive Epidemiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(16)30139-9
PubMed Identifier: 27450474
Publication URI: http://europepmc.org/abstract/MED/27450474
Type: Journal Article/Review
Volume: 15
Parent Publication: The Lancet. Neurology
Issue: 10
ISSN: 1474-4422